Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis

被引:6
|
作者
McLinden, Taylor [1 ]
Moodie, Erica E. M. [1 ]
Hamelin, Anne-Marie [1 ]
Harper, Sam [1 ]
Rossi, Carmine [1 ]
Walmsley, Sharon L. [2 ,3 ]
Rourke, Sean B. [4 ,5 ,6 ]
Cooper, Curtis [7 ]
Klein, Marina B. [8 ,9 ]
Cox, Joseph [1 ,8 ,9 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ H3A 1A2, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada
[4] Ontario HIV Treatment Network, Toronto, ON, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[7] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[8] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada
[9] CIHR Canadian HIV Trials Network, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
Methadone treatment; Severe food insecurity; HIV; Hepatitis C virus; Propensity score matching; INFECTED INDIVIDUALS; C VIRUS; PREVALENCE; PEOPLE;
D O I
10.1016/j.drugalcdep.2017.12.031
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Severe food insecurity (FI) is common among individuals living with HIV-hepatitis C virus (HCV) co-infection. We hypothesize that the injection of opioids is partly responsible for the association between injection drug use and severe FI. Therefore, this analysis examines whether methadone maintenance treatment for opioid dependence is associated with a lower risk of severe Fl. Methods: We used biannual data from the Canadian Co-infection Cohort (N = 608, 2012-2015). Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module. To quantify the association between methadone treatment and severe FI, we estimated an average treatment effect on the treated (marginal risk difference [RD]) using propensity score matching. Results: Among participants, 25% experienced severe FI in the six months preceding the first time-point in the analytical sample and 5% concurrently reported receiving methadone treatment. Injection of opioids in the six months preceding the treatment and outcome measurements was much higher among those who received methadone treatment (39% vs. 12%). Among the treated participants, 97% had injected opioids in their lifetimes. After propensity score matching, the average risk of experiencing severe FI is 12.3 percentage-points lower among those receiving methadone treatment, compared to those who are not receiving treatment (marginal RD = -0.123, 95% CI = -0.230, 0.015). Conclusions: After adjustment for socioeconomic, sociodemographic, behavioural, and clinical confounders, methadone treatment is associated with a lower risk of severe FI. This finding suggests that methadone treatment may mitigate severe FI in this vulnerable subset of the HIV-positive population.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 50 条
  • [41] Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience
    Carvalho, L.
    Pillai, S.
    Daniels, E.
    Sellers, P.
    Whyte, R.
    Eveson, L.
    Foxton, M.
    Nelson, M.
    JOURNAL OF INFECTION, 2020, 80 (02) : 245 - 246
  • [42] Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research
    Marcellin, Fabienne
    Fontaine, Helene
    Serfaty, Lawrence
    Sogni, Philippe
    Carrieri, Maria Patrizia
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (05) : 377 - 380
  • [43] Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
    Suvercha Bhardwaj
    Fareed Ahmad
    Heiner Wedemeyer
    Marcus Cornberg
    Julian Schulze zur Wiesch
    Jan van Lunzen
    Shiv K. Sarin
    Reinhold E. Schmidt
    Dirk Meyer-Olson
    Virology Journal, 13
  • [44] Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
    Bhardwaj, Suvercha
    Ahmad, Fareed
    Wedemeyer, Heiner
    Cornberg, Marcus
    zur Wiesch, Julian Schulze
    van Lunzen, Jan
    Sarin, Shiv K.
    Schmidt, Reinhold E.
    Meyer-Olson, Dirk
    VIROLOGY JOURNAL, 2016, 13
  • [45] DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HIV-HCV CO-INFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM
    Fontaine, H.
    Lacombe, K.
    Dhiver, C.
    Rosenthal, E.
    Metivier, S.
    Antonini-Michelle, T.
    Valantin, M. A.
    Cotte, L.
    Botero, J.
    Harent, S.
    Batisse, D.
    Pageaux, G. -P.
    Aumaitre, H.
    Dominguez, S.
    De Ledinghen, V.
    Leroy, V.
    Dabis, F.
    Wittkop, L.
    Filipovics, A.
    Barlet, M. H.
    Bennai, Y.
    Salmon, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S275 - S275
  • [46] Daclatasvir plus sofosbuvir with or without ribavirin in patients with HIV-HCV co-infection: interim analysis of a French multicentre compassionate use programme
    Lacombe, Karine
    Fontaine, Helene
    Dhiver, Catherine
    Rosenthal, Eric
    Metivier, Sophie
    Antonini-Michelle, Teresa
    Valantin, Marc Antoine
    Miailhes, Patrick
    Harent, Stanislas
    Batisse, Dominique
    Pageaux, Georges-Philippe
    Aumaitre, Hugues
    Dominguez, Stephanie
    Chas, Julie
    Allegre, Thierry
    Lafeuillade, Alain
    De Truchis, Pierre
    De Ledinghen, Victor
    Leroy, Vincent
    Billaud, Eric
    Sogni, Phillipe
    Dabis, Francois
    Wittkop, Linda
    Duvivier, Claudine
    Filipovics, Anne
    Fedchuk, Larysa
    Bennai, Yacia
    Salmon, Dominique
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
  • [47] A Randomized Trial Comparing Brief Advice and Motivational Interviewing for Persons with HIV-HCV Co-infection Who Drink Alcohol
    Stein, Michael D.
    Herman, Debra S.
    Kim, H. Nina
    Howell, Abigail
    Lambert, Audrey
    Madden, Stephanie
    Moitra, Ethan
    Blevins, Claire E.
    Anderson, Bradley J.
    Taylor, Lynn E.
    Pinkston, Megan M.
    AIDS AND BEHAVIOR, 2021, 25 (04) : 1013 - 1025
  • [48] Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan
    Yen, Yung-Feng
    Yen, Muh-Yong
    Su, Lien-Wen
    Li, Lan-Huei
    Chuang, Peing
    Jiang, Xiao-Ru
    Deng, Chung-Yeh
    BMC PUBLIC HEALTH, 2012, 12
  • [49] Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan
    Yung-Feng Yen
    Muh-Yong Yen
    Lien-Wen Su
    Lan-Huei Li
    Peing Chuang
    Xiao-Ru Jiang
    Chung-Yeh Deng
    BMC Public Health, 12
  • [50] Treatment of HCV Infection with Direct-acting Antiviral Agents in Patients with HIV/HCV Co-infection: A Systematic Review
    Alavian, Seyed Moayed
    Dolatimehr, Fardin
    Sharafi, Heidar
    Safi-Abadi, Mahdi
    Rezaee-Zavareh, Mohammad Saeid
    Bayatpour, Mohammad Ehsan
    Karimi-Sari, Hamidreza
    Mohazzab-Torabi, Saman
    HEPATITIS MONTHLY, 2018, 18 (12)